SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000073
Filing Date
2021-05-04
Accepted
2021-05-04 08:37:59
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-20210331.htm   iXBRL 10-Q 1940244
2 EX-31.1 kpti-20210331-ex31_1.htm EX-31.1 11412
3 EX-31.2 kpti-20210331-ex31_2.htm EX-31.2 11449
4 EX-32.1 kpti-20210331-ex32_1.htm EX-32.1 6407
5 EX-32.2 kpti-20210331-ex32_2.htm EX-32.2 6732
  Complete submission text file 0000950170-21-000073.txt   7842773

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20210331.xsd EX-101.SCH 58279
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20210331_lab.xml EX-101.LAB 507900
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20210331_def.xml EX-101.DEF 302859
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20210331_cal.xml EX-101.CAL 48030
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20210331_pre.xml EX-101.PRE 428809
11 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20210331_htm.xml XML 1312805
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 21886145
SIC: 2834 Pharmaceutical Preparations